| next >> |
| Start date | Project | acronym | role | funding | partners |
|---|
| 2022-10-01 | Metal-containing Radical Enzymes |
MetRaZymes | participant | 2.406.624 | 25 |
| 2021-11-01 | European platform for neurodegenerative disorders |
EPND | participant | 9.680.000 | 29 |
| 2021-10-01 | Shortening the path to rare disease diagnosis by using newborn genetic screening and digital technologies |
SCREEN4CARE | participant | 11.938.569 | 37 |
| 2021-07-01 | Health Initiatives in Psoriasis and PsOriatic arthritis ConsoRTium European States |
HIPPOCRATES | participant | 10.210.993 | 27 |
| 2021-02-01 | Central Repository for Digital Pathology |
BIGPICTURE | participant | 32.319.825 | 51 |
| 2020-11-01 | Accelerating Research & Development for Advanced Therapies |
ARDAT | participant | 11.773.000 | 34 |
| 2020-11-01 | Gravitate–Health: Empowering and Equipping Europeans with health information for Active Personal Health Management and Adherence to Treatment |
Gravitate-Health | participant | 9.280.000 | 42 |
| 2020-10-01 | H2O Health Outcomes Observatory |
H2O | participant | 10.476.687 | 25 |
| 2020-10-01 | HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY – PLUS |
HARMONY PLUS | participant | 6.715.625 | 41 |
| 2020-09-01 | Prioritisation and Risk Evaluation of Medicines in the EnviRonment |
PREMIER | participant | 4.550.000 | 25 |
| 2020-07-01 | C-H Activation for Industrial Renewal |
CHAIR | participant | 3.938.270 | 14 |
| 2020-05-01 | Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA |
INNODIA HARVEST | participant | 5.999.055 | 41 |
| 2020-04-01 | Corona Accelerated R&D in Europe |
CARE | participant | 36.559.186 | 43 |
| 2020-01-01 | PharmaLedger |
PharmaLedger | participant | 8.290.694 | 30 |
| 2020-01-01 | Better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies |
ImmUniverse | participant | 15.500.000 | 28 |
| 2019-12-01 | Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies |
imSAVAR | participant | 10.999.316 | 28 |
| 2019-11-01 | EU Patient- cEntric clinicAl tRial pLatform |
EU-PEARL | participant | 12.004.953 | 37 |
| 2019-10-01 | Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies |
Immune-Image | participant | 15.000.000 | 23 |
| 2019-09-01 | Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions |
3TR | participant | 40.273.192 | 70 |
| 2019-09-01 | Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials |
Trials@Home | participant | 19.036.998 | 33 |
| 2019-06-01 | MachinE Learning Ledger Orchestration for Drug DiscoverY |
MELLODDY | participant | 8.000.000 | 17 |
| 2019-04-01 | Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation |
ConcePTION | participant | 15.299.991 | 53 |
| 2019-04-01 | Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement |
MOBILISE-D | participant | 25.395.897 | 35 |
| 2019-04-01 | Biomarkers in Atopic Dermatitis and Psoriasis |
BIOMAP | participant | 10.500.000 | 32 |
| 2019-03-01 | Neurotoxicity De-Risking in Preclinical Drug Discovery |
NeuroDeRisk | participant | 5.331.000 | 18 |
| 2019-02-01 | Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease |
TransBioLine | participant | 13.999.998 | 29 |
| 2019-01-01 | NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients |
NECESSITY | participant | 8.200.000 | 25 |
| 2019-01-01 | FAIRplus |
FAIRplus | participant | 3.996.150 | 22 |
| 2019-01-01 | Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The Brain |
IM2PACT | participant | 9.000.000 | 27 |
| 2019-01-01 | Remote Assessment of Disease and Relapse – Alzheimer’s Disease |
RADAR-AD | participant | 4.999.757 | 17 |
| 2018-11-01 | European Health Data and Evidence Network |
EHDEN | participant | 14.105.750 | 22 |
| 2018-10-01 | Peroxisome Interactions and Communication |
PERICO | participant | 3.974.527 | 15 |
| 2018-09-01 | WEB-RADR 2 |
WEB-RADR 2 | participant | 1.168.750 | 12 |
| 2018-09-01 | Ensuring the future of EUPATI beyond 2020 |
EFOEUPATI | participant | 365.243 | 12 |
| 2018-07-01 | Research empowerment on solute carriers (ReSOLUTE) |
ReSOLUTE | participant | 12.000.000 | 14 |
| 2018-06-01 | Autism Innovative Medicine Studies – 2 – Trials |
AIMS-2-TRIALS | participant | 54.999.999 | 48 |
| 2018-05-01 | conect4children (COllaborative Network for European Clinical Trials For Children) |
c4c | participant | 67.000.000 | 47 |
| 2018-04-01 | Improving the care of patients suffering from acute or chronic pain |
IMI-PainCare | participant | 11.225.271 | 40 |
| 2018-03-01 | Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes. |
PARADIGM | participant | 4.498.931 | 35 |
| 2017-11-01 | Liver Investigation: Testing Marker Utility in Steatohepatitis |
LITMUS | participant | 15.797.881 | 56 |
| 2017-10-01 | European Quality In Preclinical Data |
EQIPD | participant | 4.495.523 | 30 |
| 2017-09-01 | Develop and validate appropriate and acceptable outcome measures in intermediate age-related macular degeneration for future interventional clinical trials - Sofia ref.: 116076 |
MACUSTAR | participant | 8.025.000 | 13 |
| 2017-09-01 | Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management |
eTRANSAFE | participant | 20.000.000 | 27 |
| 2017-03-01 | Big Data 4 Better Hearts - Sofia ref.: 116074 |
BigData Heart | participant | 9.664.970 | 19 |
| 2017-03-01 | Inhibiting Misfolded protein PRopagation in Neurodegenerative Diseases - Sofia ref.: 116060 |
IMPRiND | participant | 4.684.998 | 19 |
| 2017-02-01 | Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055 |
DO-IT | participant | 3.549.833 | 36 |
| 2017-01-01 | Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026 |
HARMONY | participant | 20.200.000 | 53 |
| 2016-11-01 | Real world Outcomes across the AD spectrum for better care: Multimodal data Access Platform - Sofia ref.: 116020 |
ROADMAP | participant | 3.998.250 | 26 |
| 2016-10-01 | Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 |
PREFER | participant | 6.000.000 | 33 |
| 2016-04-01 | Psychiatric Ratings using Intermediate Stratified Markers - Sofia ref.: 115916 |
PRISM | participant | 8.080.000 | 23 |
| next >> |
